Ignite Creation Date:
2025-12-24 @ 4:35 PM
Ignite Modification Date:
2026-02-21 @ 6:24 AM
Study NCT ID:
NCT03214666
Status:
TERMINATED
Last Update Posted:
2022-11-10
First Post:
2017-07-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
GTB-3550 Tri-Specific Killer Engager (TriKE®) for High Risk Hematological Malignancies
Sponsor:
GT Biopharma, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-01-01
Start Date Type:
ACTUAL
Primary Completion Date:
2021-08-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-09-29
Completion Date Type:
ACTUAL
First Submit Date:
2017-07-07
First Submit QC Date:
None
Study First Post Date:
2017-07-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-09-07
Results First Submit QC Date:
None
Results First Post Date:
2022-11-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-10-14
Last Update Post Date:
2022-11-10
Last Update Post Date Type:
ACTUAL